saxagliptin

FDA Drug Profile — Saxagliptin

saxagliptin is listed in the FDA National Drug Code directory with 3 NDC codes, marketed under brand name including Saxagliptin. Available dosage forms: powder, tablet, film coated.

Drug details

Generic Name
saxagliptin
Brand Names
Saxagliptin
Application Number
ANDA205980
Sponsor
SK BIOTEK IRELAND LIMITED
NDC Codes
3
Dosage Forms
POWDER, TABLET, FILM COATED
Routes
ORAL
Active Ingredients
SAXAGLIPTIN MONOHYDRATE, SAXAGLIPTIN HYDROCHLORIDE DIHYDRATE

Indications and Usage

1 INDICATIONS AND USAGE Saxagliptin tablets are a dipeptidyl peptidase-4 (DPP-4) inhibitor indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. ( 1.1 ) Limitations of use: • Not recommended for the treatment of type 1 diabetes mellitus or diabetic ketoacidosis. ( 1.2 ) 1.1 Monotherapy and Combination Therapy Saxagliptin tablets are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus [ see Clinical Studies ( 14 ) ]. 1.2 Limitation of Use Saxagliptin tablets are not recommended for the treatment of type 1 diabetes mellitus or diabetic ketoacidosis. 1.1 Monotherapy and Combination Therapy Saxagliptin tablets are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus [ see Clinical Studies ( 14 ) ].

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.